Nolz-1 inhibitors belong to a specialized class of chemical compounds designed to target the Nolz-1 (Nuclear Protein Localized to Z-bodies 1) protein. Nolz-1, also known as Zfp503, is a transcription factor that plays a significant role in embryonic development and tissue-specific gene regulation. It is part of the Krüppel-like zinc finger protein family, characterized by the presence of C2H2-type zinc finger motifs involved in DNA binding and gene expression control. Nolz-1 is known for its involvement in processes such as neural tube development, axon guidance, and the differentiation of specific cell types, particularly in the nervous system. It exerts its regulatory influence by binding to specific DNA sequences and modulating the expression of target genes.
Inhibitors of Nolz-1 are designed to interact with this transcription factor and disrupt its DNA binding capabilities or affect its ability to regulate gene expression. These inhibitors may operate through various mechanisms, such as binding to specific regions of Nolz-1 or altering its conformation. By inhibiting Nolz-1, these compounds can impact the intricate gene regulatory networks governing embryonic development and tissue-specific differentiation, offering insights into the molecular basis of tissue patterning and cellular diversity during organogenesis. Research on Nolz-1 inhibitors is primarily focused on elucidating the molecular mechanisms by which Nolz-1 influences gene expression in various developmental contexts, contributing to our understanding of the genetic pathways that orchestrate embryonic development and tissue-specific differentiation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially reducing overall protein levels, including Nolz-1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis and could inhibit the transcription of genes like Nolz-1. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that inhibits transcription broadly and may decrease Nolz-1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting the epigenetic status of the Nolz-1 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it may demethylate DNA and affect gene expression, including Nolz-1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that could alter histone acetylation and gene expression profiles, including potentially Nolz-1. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
A cyclin-dependent kinase inhibitor, which might affect the cell cycle and related transcription factor expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates degradation of transcription factors, potentially affecting the levels of Nolz-1 indirectly. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor that can influence Notch signaling, potentially affecting Nolz-1 expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid that modulates various cellular processes and may influence the expression of transcription factors. | ||||||